| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 01/15/1997 | EP0753010A1 A novel expression-cloning method for identifying target proteins for eukaryotic tyrosine kinases and novel target proteins |
| 01/15/1997 | EP0752876A1 Monoclonal anbibodies which bind to tumor rejection antigen precursor mage-1, recombinant mage-1, and mage-1 derived immunogenic peptides |
| 01/15/1997 | EP0752872A1 Nadh oxidase as a target in diagnosis and therapy |
| 01/15/1997 | EP0752869A1 Cells with multiple altered epitopes on a surface antigen for use in transplantation |
| 01/15/1997 | EP0752868A1 Improved methods for transplantation using modified cells and t cell inhibitory agents |
| 01/15/1997 | EP0752853A1 Human brain phosphodiesterase |
| 01/15/1997 | EP0752844A1 Human osteoclast-derived cathepsin |
| 01/15/1997 | EP0736106A4 Methods of screening for beta-amyloid peptide production inhibitors |
| 01/15/1997 | CN1140414A Use of anti-TNF antibodies as drugs in treating diseases involving elevated interleukin-6 serum levels |
| 01/15/1997 | CN1140413A Humanized antibodies against leukocyte adhesion molecule VLA-4 |
| 01/14/1997 | US5594120 Integrin alpha subunit |
| 01/14/1997 | US5594116 Inoculating an avian; isolating immunoglobulins; binding to affinity matrix; elution |
| 01/14/1997 | US5594112 Acridinium compounds and conjugates thereof |
| 01/14/1997 | US5593969 Lipid-A analogs: monosaccharide and dissaccharide compounds for inhibiting binding of lipid A receptors to lipid A receptors |
| 01/14/1997 | US5593896 Competitive immunoassay |
| 01/14/1997 | US5593884 Oncoprotein protein kinase |
| 01/14/1997 | US5593882 Selectin variants |
| 01/14/1997 | US5593876 Nitrosylation of protein SH groups and amino acid residues as a therapeutic modality |
| 01/14/1997 | US5593861 Dog-mouse heterohybridoma and gene fragment coding for constant region of canine immunoglobulins |
| 01/14/1997 | US5593850 Monitoring of industrial water quality using monoclonal antibodies to polymers |
| 01/14/1997 | US5593846 Methods for the detection of soluble β-amyloid peptide |
| 01/14/1997 | US5593844 Ligand-mediated immunofunctional hormone binding protein assay method |
| 01/14/1997 | US5593825 Hepatitis B virus mutants, reagents and methods for detection |
| 01/14/1997 | US5593677 Antimonoclonal antibodies for leukemia |
| 01/14/1997 | US5593676 Method of killing B cells using antibodies which bind CDIM |
| 01/14/1997 | US5593675 Method of producing an anti-D immunoglobulin concentrate and a pharmaceutical preparation |
| 01/14/1997 | CA1338841C Monoclonal antibodies specific for human fibrinopeptide a |
| 01/09/1997 | WO1997000961A1 Plant regulatory proteins iii |
| 01/09/1997 | WO1997000956A1 Hypoxia-responsive adhesion molecules, specific antibodies, and their uses |
| 01/09/1997 | WO1997000952A2 A human edg-2 receptor homolog |
| 01/09/1997 | WO1997000946A1 Immortalized epithelial tumor cell |
| 01/09/1997 | WO1997000892A2 Depigmenting activity of agouti signal protein and peptides thereof |
| 01/09/1997 | WO1997000888A1 Methods for reducing background binding in antibody preparations |
| 01/09/1997 | WO1996039511A3 A c5a-like seven transmembrane receptor |
| 01/09/1997 | WO1996034088A3 Control of floral induction in plants and uses therefor |
| 01/09/1997 | WO1996032137A3 Methods of inducing immune tolerance using immunotoxins |
| 01/09/1997 | CA2225600A1 Gibberellin-regulated myb polypepetides |
| 01/09/1997 | CA2224799A1 A human edg-2 receptor homolog |
| 01/09/1997 | CA2224797A1 Immortalized epithelial tumor cell |
| 01/09/1997 | CA2224691A1 Depigmenting activity of agouti signal protein and peptides thereof |
| 01/09/1997 | CA2224687A1 Methods for reducing background binding in antibody preparations |
| 01/08/1997 | EP0752473A2 Cloning and characterization of H. pylori flbA gene: production of flagella-free strains |
| 01/08/1997 | EP0752425A2 Peptide ligands for the constant region of immunoglobulins |
| 01/08/1997 | EP0752248A1 Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma |
| 01/08/1997 | EP0752103A1 Methods for detecting calpain activation and indentifying calpain inhibitors |
| 01/08/1997 | EP0752097A1 Covalent immobilized antibodies on polymeric beads |
| 01/08/1997 | EP0752008A1 Dna mutagenesis by random fragmentation and reassembly |
| 01/08/1997 | EP0752005A1 Compacted nucleic acids and their delivery to cells |
| 01/08/1997 | EP0751992A1 Vascular endothelial growth factor 2 |
| 01/08/1997 | EP0751987A1 Genetically modified cells for use in transplantation |
| 01/08/1997 | EP0751962A1 Methods and compositions for inhibiting cd14 mediated cell activation |
| 01/08/1997 | EP0751960A1 Synthetic inverso or retro-inverso t-cell epitopes |
| 01/08/1997 | EP0751957A1 Peptide fragments of microbial stress proteins and pharmaceutical composition made thereof for the treatment and prevention of inflammatory diseases |
| 01/08/1997 | EP0751787A1 Method for reducing immune and hemostatic dysfunctions during extracorporeal circulation |
| 01/08/1997 | EP0751786A1 Urease-based vaccine and treatment for helicobacter infection |
| 01/08/1997 | EP0751782A1 Methods for altering fertility |
| 01/08/1997 | EP0751781A1 Method of preventing or treating disease characterized by neoplastic cells expressing cd40 |
| 01/08/1997 | EP0751780A1 Methods of isolating cd1-presented antigens, vaccines comprising cd1-presented antigens, and cell lines for use in said methods |
| 01/08/1997 | EP0751709A1 Methods of using bcl-2 for the therapeutic treatment and prevention of diseases |
| 01/08/1997 | EP0580672B1 SYNTHETIC CDw52(CAMPATH-1) PEPTIDE ANTIGEN |
| 01/08/1997 | EP0497828B1 A process for endoproteolytically processing (precursor) proteins and for the (micro)biological production of proteins |
| 01/08/1997 | EP0473724B1 A human cytokine, interleukin-9 |
| 01/08/1997 | EP0386166B1 PROTAMINE-REACTIVE IgM ANTIBODIES |
| 01/08/1997 | EP0273928B1 A PROTEIN ACTIVE IN HUMORAL HYPERCALCEMIA OF MALIGNANCY-PTHrP |
| 01/08/1997 | CN1139871A Novel apopotsis-modulating proteins, DNA encoding the proteins and methods of use thereof |
| 01/08/1997 | CN1033760C Protein with 8th activity factor, process for its preparation using genetic engineering cell and pharmaceutical composition containing it |
| 01/07/1997 | US5591831 Medical diagnosing, drug screening |
| 01/07/1997 | US5591830 Detection of complexes which include basement membrane components as diagnostic of cancer and other diseases |
| 01/07/1997 | US5591829 Antibodies modified with toxic substance |
| 01/07/1997 | US5591828 Genetic engineering |
| 01/07/1997 | US5591825 Dna and transducers |
| 01/07/1997 | US5591824 Porcine apamin binding protein/receptor |
| 01/07/1997 | US5591710 Compositions and methods utilizing nitroxides to avoid oxygen toxicity, particularly in stabilized, polymerized, conjugated, or encapsulated hemoglobin used as a red cell substitute |
| 01/07/1997 | US5591669 Transgenic mice depleted in a mature lymphocytic cell-type |
| 01/07/1997 | US5591648 Antibodies for mevalonic acid and methods for immunological determination of mevalonic acid by using them |
| 01/07/1997 | US5591633 Nucleic acids encoding human placental coagulation inhibitor (PCI) |
| 01/07/1997 | US5591631 Anthrax toxin fusion proteins, nucleic acid encoding same |
| 01/07/1997 | US5591629 Monoclonal antibodies which promote central nervous system remyelination |
| 01/07/1997 | US5591620 Methods of detecting and isolating a ripening form of a polypeptide having rhamnogalacturonase activity |
| 01/07/1997 | US5591604 Recombinant antibodies at the surface of E. coli |
| 01/07/1997 | US5591602 Nucleic acid encoding opioid receptor |
| 01/07/1997 | US5591595 Detection of complexes which include basement membrane components as diagnostic of cancer and other diseases |
| 01/07/1997 | US5591593 Peptide sequence which binds to a mucin expressed by an epithelial tumor |
| 01/07/1997 | US5591592 Method for detection of fibronectin receptor ligands |
| 01/07/1997 | US5591587 Determining antigenic activity in urine; contacting with receptor that binds oncoproteins |
| 01/07/1997 | US5591583 Human restrictin and nucleic acid sequences |
| 01/07/1997 | US5591574 Probes, diagnostic method and immunization method based on papillomavirus types HPV 49 and HPV 50 |
| 01/07/1997 | US5591572 Aids, hiv |
| 01/07/1997 | US5591440 Hepatitis B Virus mutants, reagents and methods for detection |
| 01/07/1997 | US5591434 DNA sequence encoding surface protein of cryptosporidium parvum |
| 01/07/1997 | US5591432 Antibody to the neural cell adhesion molecule and methods of use |
| 01/07/1997 | CA2025315C Protein-containing aqueous solutions |
| 01/07/1997 | CA1338828C Bispecific antibody determinants |
| 01/03/1997 | WO1997000445A1 Process for producing gm2 specific antibodies |
| 01/03/1997 | WO1997000319A2 Chimeric leptin fused to immunoglobulin domain and use |
| 01/03/1997 | WO1997000318A1 Osteoclast growth regulatory factor |
| 01/03/1997 | WO1997000271A1 Novel high affinity human antibodies to tumor antigens |
| 01/03/1997 | WO1997000088A2 Rotavirus enterotoxin nsp4 and methods of using same |
| 01/03/1997 | WO1997000079A1 P-selectin ligands and related molecules and methods |
| 01/03/1997 | WO1997000077A1 Anti-metastatic and anti-angiogenic pharmaceutical compositions |